261 related articles for article (PubMed ID: 33740587)
1. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis.
Misiak B; Bartoli F; Carrà G; Stańczykiewicz B; Gładka A; Frydecka D; Samochowiec J; Jarosz K; Hadryś T; Miller BJ
Psychoneuroendocrinology; 2021 May; 127():105200. PubMed ID: 33740587
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis.
Park S; Miller BJ
Schizophr Res; 2020 Dec; 226():5-12. PubMed ID: 30967316
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
[TBL] [Abstract][Full Text] [Related]
4. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study.
Khandaker GM; Pearson RM; Zammit S; Lewis G; Jones PB
JAMA Psychiatry; 2014 Oct; 71(10):1121-8. PubMed ID: 25133871
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory biomarkers in psychosis and clinical high risk populations.
Delaney S; Fallon B; Alaedini A; Yolken R; Indart A; Feng T; Wang Y; Javitt D
Schizophr Res; 2019 Apr; 206():440-443. PubMed ID: 30414721
[TBL] [Abstract][Full Text] [Related]
6. A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis.
Pillinger T; Osimo EF; Brugger S; Mondelli V; McCutcheon RA; Howes OD
Schizophr Bull; 2019 Sep; 45(5):1120-1133. PubMed ID: 30407606
[TBL] [Abstract][Full Text] [Related]
7. Changes in Inflammatory Markers in Clinical High Risk of Developing Psychosis.
Zhang T; Zeng J; Wei Y; Ye J; Tang X; Xu L; Hu Y; Liu H; Chen T; Li C; Wang J
Neuropsychobiology; 2023; 82(2):104-116. PubMed ID: 36796338
[TBL] [Abstract][Full Text] [Related]
8. Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms.
Stojanovic A; Martorell L; Montalvo I; Ortega L; Monseny R; Vilella E; Labad J
Psychoneuroendocrinology; 2014 Mar; 41():23-32. PubMed ID: 24495605
[TBL] [Abstract][Full Text] [Related]
9. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
Khoury R; Nasrallah HA
Schizophr Res; 2018 Sep; 199():31-38. PubMed ID: 29703661
[TBL] [Abstract][Full Text] [Related]
11. Salivary cortisol in early psychosis: New findings and meta-analysis.
Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
[TBL] [Abstract][Full Text] [Related]
12. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T; Seidman L; Tsuang M; Woods SW; Walker EF; Perkins DO
Brain Behav Immun; 2019 Feb; 76():268-274. PubMed ID: 30496778
[TBL] [Abstract][Full Text] [Related]
13. Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis.
Misiak B; Stańczykiewicz B; Łaczmański Ł; Frydecka D
Schizophr Res; 2017 Dec; 190():18-27. PubMed ID: 28325572
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor in patients with schizophrenia: A systematic review and meta-analysis.
Misiak B; Stramecki F; Stańczykiewicz B; Frydecka D; Lubeiro A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():24-29. PubMed ID: 29772306
[TBL] [Abstract][Full Text] [Related]
15. Serum immune markers and transition to psychosis in individuals at clinical high risk.
Mondelli V; Blackman G; Kempton MJ; Pollak TA; Iyegbe C; Valmaggia LR; Amminger P; Barrantes-Vidal N; Bressan R; van der Gaag M; de Haan L; Krebs MO; Nordentoft M; Ruhrmann S; Riecher-Rössler A; Rutten BPF; Sachs G; Koutsouleris N; ; McGuire P
Brain Behav Immun; 2023 May; 110():290-296. PubMed ID: 36940754
[TBL] [Abstract][Full Text] [Related]
16. Immune and oxidative stress biomarkers in pediatric psychosis and psychosis-risk: Meta-analyses and systematic review.
Taylor JH; Bermudez-Gomez J; Zhou M; Gómez O; Ganz-Leary C; Palacios-Ordonez C; Huque ZM; Barzilay R; Goldsmith DR; Gur RE
Brain Behav Immun; 2024 Mar; 117():1-11. PubMed ID: 38141839
[TBL] [Abstract][Full Text] [Related]
17. Monocyte count in schizophrenia and related disorders: a systematic review and meta-analysis.
Mazza MG; Capellazzi M; Lucchi S; Tagliabue I; Rossetti A; Clerici M
Acta Neuropsychiatr; 2020 Oct; 32(5):229-236. PubMed ID: 32178747
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.
Liu C; Feng X; Li Q; Wang Y; Li Q; Hua M
Cytokine; 2016 Oct; 86():100-109. PubMed ID: 27498215
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis.
Misiak B; Wójta-Kempa M; Samochowiec J; Schiweck C; Aichholzer M; Reif A; Samochowiec A; Stańczykiewicz B
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Aug; 118():110581. PubMed ID: 35660454
[TBL] [Abstract][Full Text] [Related]
20. Measuring Disturbance of the Endocannabinoid System in Psychosis: A Systematic Review and Meta-analysis.
Minichino A; Senior M; Brondino N; Zhang SH; Godwlewska BR; Burnet PWJ; Cipriani A; Lennox BR
JAMA Psychiatry; 2019 Sep; 76(9):914-923. PubMed ID: 31166595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
